Truqap is often a kinase inhibitor that works by blocking pathways that support the most cancers cells survive and develop, so minimizes most cancers development. Truqap is from a category of medicines identified as an AKT inhibitor. Truqap gained FDA acceptance on November seventeen, 2023, just aft